Faculty Information |
|
Language | English |
The announcement title | Hepatocellular carcinoma development in Japanese patients with HCV genotype 1 infection who achieved sustained virologic response by ledipasvir/sofosbuvir and protease inhibitor with peginterferon plus ribavirin. |
Academic Society name | The 68th Annual Meeting of the American Association for the Study of Liver Diseases |
Promoters | American Association for the Study of Liver Diseases |
Conference Type | International Society |
Announcement form | Poster presentation |
Lecture Type | Poster sessions |
Publisher and common publisher | Korenaga Masaaki, Izumi Namiki, Yokosuka Osamu, Takehara Tetsuo, Sakamoto Naoya, Nishiguchi Shuhei, Ikeda Fusao, Yanase Mikio, Toyoda Hidenori, Genda Takuya, Umemura Takeji, Yatsuhashi Hiroshi, Ide Tatsuya, Toda Nobuo, Nirei Kazushige, Ueno Yoshiyuki, Nishigaki Yoichi, Nakane Kunio, Kanto Tatsuya, Omata Masao, Mizokami Masashi. |
Date | 2017/10/21 |
Venue (city and name of the country) |
Washington DC |
Society abstract | Hepatology 66(suppl1),563A 2017 |